CoVac-1 Completed Phase 0 Trials for Metastatic Breast Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment0
clinicaltrials.gov IdentifierTitleDrugs
NCT01660529Multi-peptide Vaccine With Basilixumab for Breast Cancer